RemSleep Holdings Inc. (RMSL) stock: key figures, P/E, revenue and dividend
Consumer Discretionary · United States · ISIN US75990A2006
RemSleep Holdings Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 16,721.00 USD |
| Gross profit | 4,014.00 USD |
| Operating income | -2.77 m USD |
| EBIT | -2.63 m USD |
| Net income | -3.02 m USD |
| Diluted EPS – continuing operations | 0.00 USD |
Full history since 2007, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About RemSleep Holdings Inc.
REMSleep Holdings, Inc., focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves durable medical equipment providers, hospital and acute care facilities, sleep labs, physicians, sleep and neurology, and medical associations. The company is headquartered in Blackshear, Georgia.
More stocks
- REVELATION BIOSCIENCES, INC. (REVB)
- Expion360 Inc. (XPON)
- LIBERTY STAR URANIUM & METALS CORP. (LBSR)
- Decoy Therapeutics Inc. (DCOY)
- Tianci International, Inc. (CIIT)
- Kindcard, Inc. (KCRD)
- Wright Investors Service Holdings, Inc. (IWSH)
- HeartCore Enterprises, Inc. (HTCR)
- NEXTNRG, INC. (NXXT)
- CID Holdco, Inc. (DAIC)
- XCel Brands, Inc. (XELB)
- Onfolio Holdings, Inc (ONFO)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.